Abstract |
After a long history of anti-infective therapeutic use, macrolide antibiotics have not yet given up all their secrets. Interest in their therapeutic potential in inflammatory diseases (possibly including non-infectious diseases) has generated abundant fundamental research and therapeutic trials worldwide. The main question regarding the future prospects of this class of drugs is whether some macrolides are beneficial in such settings because they modulate host inflammatory responses (and cellular targets) or rather because they eliminate a latent, unidentified pathogen which triggers chronic inflammation. However, no clearcut results have yet been obtained.
|
Authors | Marie-Thérèse Labro |
Journal | Expert opinion on pharmacotherapy
(Expert Opin Pharmacother)
Vol. 5
Issue 3
Pg. 541-50
(Mar 2004)
ISSN: 1465-6566 [Print] England |
PMID | 15013923
(Publication Type: Journal Article, Review)
|
Chemical References |
- Anti-Infective Agents
- Anti-Inflammatory Agents, Non-Steroidal
- Macrolides
|
Topics |
- Anti-Infective Agents
(therapeutic use)
- Anti-Inflammatory Agents, Non-Steroidal
(therapeutic use)
- Arteriosclerosis
(drug therapy)
- Asthma
(drug therapy)
- Clinical Trials as Topic
- Humans
- Inflammation
(drug therapy)
- Macrolides
(therapeutic use)
|